LifeStance Health (LFST) Operating Leases (2022 - 2026)

LifeStance Health (LFST) has reported Operating Leases for 5 consecutive years, with $148.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Operating Leases changed 0.38% year-over-year to $148.8 million; the TTM figure through Mar 2026 stood at $148.8 million (changed 0.38% YoY), while the FY2025 annual figure was $148.6 million, changed 0.1% from the prior year.
• Operating Leases held at $148.8 million in Q1 2026 per LFST's latest filing, from $148.6 million in the prior quarter.
• Across five years, Operating Leases topped out at $212.6 million in Q4 2022 and bottomed at $143.4 million in Q2 2025.
• Historically, Operating Leases has averaged $170.0 million across 5 years, with a median of $162.2 million in 2024.
• Annual changes were most pronounced in 2024 — Operating Leases decreased 19.38% — and 2025, when it dropped 0.1%.
• LifeStance Health's Operating Leases stood at $212.6 million in 2022, then declined by 14.69% to $181.4 million in 2023, then decreased by 18.01% to $148.7 million in 2024, then slipped by 0.1% to $148.6 million in 2025, then climbed by 0.18% to $148.8 million in 2026.
• Business Quant data shows LFST's Operating Leases at $148.8 million in Q1 2026, $148.6 million in Q4 2025, and $144.2 million in Q3 2025.